RedPath Integrated Pathology, Inc.

30 articles about RedPath Integrated Pathology, Inc.

• PDI, Inc. Rejects Digirad Corporation Buyout Offer, Snags RedPath Integrated Pathology, Inc. Instead

  11/5/2014

• RedPath Integrated Pathology, Inc. Release: Independent Study Highlights The Importance Of Molecular Testing In Predicting Biologic Behavior Of Pancreatic Cysts

  11/3/2014

• PDI, Inc. Reports 2014 Third Quarter Financial Results; Acquires RedPath Integrated Pathology, Inc.

  11/3/2014

• RedPath Integrated Pathology, Inc. Announces Publication Of Study In Endoscopy Showing The Accuracy Of Pathfindertg® In Managing Pancreatic Cysts

  10/24/2014

• RedPath Integrated Pathology, Inc. Announces Presentations At 2014 Digestive Disease Week Meeting

  5/2/2014

• RedPath Integrated Pathology, Inc. Welcomes Alan Fishman As New Chief Financial Officer

  3/6/2014

• RedPath Integrated Pathology, Inc. Executes Agreement With MultiPlan Preferred Provider Network

  2/24/2014

• RedPath Integrated Pathology, Inc. President and CEO To Speak At Upcoming Piper Jaffray Healthcare Conference

  11/19/2013

• RedPath Integrated Pathology, Inc. Executes Agreements With Three National Healthcare Preferred Provider Networks

  10/28/2013

• RedPath Integrated Pathology, Inc. Announces Results of National Pancreatic Cyst Registry at 2013 ACG Annual Meeting

  10/21/2013

• RedPath Integrated Pathology, Inc. Receives Two Technology Grants for Development of PathFinderTG(R) Platform

  11/9/2010

• RedPath Integrated Pathology, Inc. Terminates Deal with ExonHit Therapeutics SA

  10/27/2010

• ExonHit Therapeutics Inc. Announces Termination of Agreement to Acquire RedPath Integrated Pathology, Inc.

  10/25/2010

• Positive Reimbursement Coverage Issued for RedPath Integrated Pathology, Inc.’s PathFinderTG(R) Technology

  9/27/2010

• ExonHit Therapeutics Inc. Updates its Shareholders Regarding the Extraordinary Shareholders’ Meeting About RedPath Integrated Pathology, Inc. Acquisition

  6/23/2010

• ExonHit Therapeutics Inc. Updates its Shareholders on the Acquisition of RedPath Integrated Pathology, Inc.

  6/18/2010

• ExonHit Therapeutics Inc. Discloses the Final Terms of the Acquisition of RedPath Integrated Pathology, Inc.

  6/9/2010

• ExonHit Therapeutics SA Announces the Holding of an Extraordinary Shareholders' Meeting to Approve the Acquisition of RedPath Integrated Pathology, Inc.

  5/26/2010

• ExonHit Therapeutics Inc. Buying RedPath Integrated Pathology, Inc. for $32 Million

  4/27/2010

• RedPath Integrated Pathology, Inc. Acquired By ExonHit Therapeutics SA

  4/26/2010